Anaptysbio Inc (ANAB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -97,336 | -61,656 | -30,070 | -4,259 | -5,405 |
| Depreciation Amortization | -1,226 | -918 | 183 | 233 | 274 |
| Accounts receivable | 174 | 1,427 | 3,742 | -4,117 | 229 |
| Other Working Capital | 15,958 | 3,461 | 4,075 | -7,026 | -6,557 |
| Other Operating Activity | 12,913 | 9,180 | 2,632 | 6,139 | 1,765 |
| Operating Cash Flow | $-69,517 | $-48,506 | $-19,438 | $-9,030 | $-9,694 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -805 | -1,063 | -290 | -50 | -238 |
| Purchase Of Investment | -251,815 | -347,537 | -290,905 | N/A | N/A |
| Sale Of Investment | 384,051 | 206,149 | 48,137 | N/A | N/A |
| Investing Cash Flow | $131,431 | $-142,451 | $-243,058 | $-50 | $-238 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | 10,000 | N/A |
| Common Stock Issued | 3,007 | 230,421 | 294,052 | 31 | 160 |
| Common Stock Repurchased | N/A | N/A | N/A | -1 | 0 |
| Other Financing Activity | -7,500 | -7,057 | -1,599 | -1,402 | 39,243 |
| Financing Cash Flow | $-4,493 | $223,364 | $292,453 | $8,628 | $39,403 |
| Beginning Cash Position | 113,656 | 81,249 | 51,292 | 51,744 | 22,273 |
| End Cash Position | 171,077 | 113,656 | 81,249 | 51,292 | 51,744 |
| Net Cash Flow | $57,421 | $32,407 | $29,957 | $-452 | $29,471 |
| Free Cash Flow | |||||
| Operating Cash Flow | -69,517 | -48,506 | -19,438 | -9,030 | -9,694 |
| Capital Expenditure | -805 | -1,063 | -290 | -50 | -238 |
| Free Cash Flow | -70,322 | -49,569 | -19,728 | -9,080 | -9,932 |